2019
DOI: 10.1016/j.spinee.2018.08.006
|View full text |Cite
|
Sign up to set email alerts
|

The impact of obesity on the effectiveness of spinal cord stimulation in chronic spine-related pain patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
22
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(24 citation statements)
references
References 27 publications
2
22
0
Order By: Relevance
“…Interestingly, treatment parameters such as SCS waveform correlated with successful trials. Our finding that pain location is significant echoes prior reports (16)(17)(18) that support the superior efficacy of SCS for lower extremity pain. In contrast to previous findings, however, pain symptoms such as allodynia or hyperalgesia were not relevant factors; neither were neuropathic vs nociceptive pain (15,(19)(20).…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Interestingly, treatment parameters such as SCS waveform correlated with successful trials. Our finding that pain location is significant echoes prior reports (16)(17)(18) that support the superior efficacy of SCS for lower extremity pain. In contrast to previous findings, however, pain symptoms such as allodynia or hyperalgesia were not relevant factors; neither were neuropathic vs nociceptive pain (15,(19)(20).…”
Section: Discussionsupporting
confidence: 87%
“…Primary pain site was a significant factor (P = .032), with the lower extremity being the most frequent location of pain among successful subjects (86%). Some factors not previously reported in the literature were found to be significant (16); the stimulator waveform was strongly associated with a successful trial (P = .003), with the paresthesia based (PB) tonic waveform being most frequently associated with a positive outcome (46.4%), followed by burst (33.8%), and then the paresthesia free (PF) high frequency waveform (11.3%). Patients had similar pain scores across the board before initiating an SCS trial (mean pain score 8 out of 10).…”
Section: Resultsmentioning
confidence: 84%
“…In addition to obesity-induced disorders, clinical evidence suggests that pain conditions development in obese subjects, such as low back pain [46][47][48][49][50][51][52][53][54][55][56], musculoskeletal pain [57][58][59][60][61][62][63], osteoarthritis pain [64][65][66], knee pain [67][68][69][70], hip pain [71], foot pain [72], spine-related pain [73], migraine and/or headache [74][75][76][77][78][79][80], orofacial pain [81,82], and postsurgical pain [83]. Research shows that physical exercise may relieve obesity-induced pain in affected subjects [84][85][86][87][88][89].…”
Section: Introductionmentioning
confidence: 99%
“…It should be noted that a large number of patients who end up with an SCS system suffer from FBSS, which is exacerbated by obesity. However, only a few studies have addressed this particular issue (Marola et al., 2017; Mekhail et al., 2019). Finally, the relationship between male gender and lower success rate of HF10‐SCS therapy lacks a clear explanation and should not be overstated considering the potential bias related to the small sample size, although there are some studies with a higher sample size that show similar trends (Bir et al., 2016).…”
Section: Discussionmentioning
confidence: 99%